PGP and esophageal squamous cell carcinoma: Although CEH has been used as an antitumor agent and MDR-reversing agent in different types of cancers and one of the its identified MDR mechanisms include inhibition of P-gp expression and function, what its antitumor effect is and whether the MDR can be reversed in ESCC remains largely unknown.